Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Sheep toxin could be linked to MS
“There is a growing body of wider evidence that points to a hypothesis linking MS and ETX".

Discovery could lead to new tests and treatments 

Scientists say exposure to a toxin found in sheep could be linked to the development of multiple sclerosis (MS) in humans.

A study by the University of Exeter and MS Sciences Ltd found that people with MS are more likely to have antibodies against the epsilon toxin (ETX), which suggests they have been exposed to it at some point.

ETX is produced in the gut of livestock by the bacterium, Clostridium perfringens. Whilst it can occur in other animals and even soil, it has primarily been studied as a cause of enterotoxaemia in sheep.

Researchers found 43 per cent of patients with MS were positive for antibodies to ETX, compared to 16 per cent of healthy participants.

Simon Slater, director of MS Sciences Ltd, said: “There is a growing body of wider evidence that points to a hypothesis linking MS and ETX, and we are confident that these significant findings from our latest study will help people get even closer to an answer for the elusive triggers of MS”.

If the link is proven, it would suggest that a vaccine could prevent MS in the early stages of the disease, Slater added.

However, the causes of the disease are not yet fully understood and further research is needed to understand how ETX may be involved in MS and how such findings could be used to develop tests or treatments.

MS is most commonly diagnosed in patients in their 20s and 30s and can affect the brain, causing a wide range of symptoms including problems with vision, movement, sensation and balance. It is estimated that more than a 100,000 people in the UK are diagnosed with MS.

The full research paper is published in the Multiple Sclerosis Journal: Click here

Become a member or log in to add this story to your CPD history

VMD invites students to apply for EMS placement

News Story 1
 The Veterinary Medicines Directorate (VMD) is inviting applications from veterinary students to attend a one-week extramural studies (EMS) placement in July 2026.

Students in their clinical years of study have until 28 February to apply for the placement, which takes place at the VMD's offices in Addlestone, Surrey, from 6-10 July 2026.

Through a mixture of lectures and workshops, the placement will explore how veterinary medicines are authorised, non-clinical career opportunities, and other important aspects of the VMD's work.  

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk